# Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

Study · id `cardio:ct-nct05765175` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05765175](<https://clinicaltrials.gov/study/NCT05765175>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05765175

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.

## Technical summary

Registry record NCT05765175. Randomized; no masking; primary purpose treatment. Start 2023-04-21 (actual); primary completion 2028-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 380 participants (planned count; ClinicalTrials.gov record NCT05765175, source copy `cardio:ctgov-nct05765175-2026-10-30`, retrieved 2026-10-31)
- Started: 2023-04-21 (actual) (ClinicalTrials.gov record NCT05765175, source copy `cardio:ctgov-nct05765175-2026-10-30`, retrieved 2026-10-31)
- Primary completion: 2028-10 (anticipated) (ClinicalTrials.gov record NCT05765175, source copy `cardio:ctgov-nct05765175-2026-10-30`, retrieved 2026-10-31)
- Completion: 2032-05 (anticipated) (ClinicalTrials.gov record NCT05765175, source copy `cardio:ctgov-nct05765175-2026-10-30`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05765175, source copy `cardio:ctgov-nct05765175-2026-10-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05765175-2026-10-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
- Acronym: RADIATE-VT
- Condition: Tachycardia, Ventricular
- Intervention (Device): Varian Cardiac Radioablation (CRA)
- Intervention (Procedure): Catheter Ablation (CA)
- Lead sponsor: Varian, a Siemens Healthineers Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)

## Provenance

Content hash: d7344501d4492f7b2e3072b9d8f784e3e123eaabe021ffcd45f3d8cbd056fcd5
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
